Last update 21 Nov 2024

Regadenoson

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Lexiscan, Regadenoson Hydrate, 瑞加诺生
+ [4]
Target
Mechanism
A2aR agonists(Adenosine A2a receptor agonists)
Login to view timeline

Structure

Molecular FormulaC15H18N8O5
InChIKeyLZPZPHGJDAGEJZ-AKAIJSEGSA-N
CAS Registry313348-27-5
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Heart Diseases
CN
26 Oct 2021
Heart Diseases
CN
26 Oct 2021
Coronary angiography
NO
06 Sep 2010
Coronary angiography
LI
06 Sep 2010
Coronary angiography
EU
06 Sep 2010
Coronary angiography
IS
06 Sep 2010
Contrast agents
US
10 Apr 2008
Myocardial Ischemia
US
10 Apr 2008
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Contrast agentsPhase 1
CN
02 Jan 2022
Pulmonary Disease, Chronic ObstructivePhase 1
US
01 Jan 2009
Coronary Artery DiseasePhase 1
US
01 Oct 2003
Coronary Artery DiseasePhase 1
US
01 Oct 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
161
lbrtmtpdxw(nhpkitvydu) = nqpincjvpo lqhirempln (qcrhufqxla, mhuojesckr - jrvxpillna)
-
02 Oct 2024
Not Applicable
-
-
tfajwrvgrx(aaxqjrmpfg) = 50.0% dqwnckqaib (ktcjugxyfg )
-
19 May 2024
Phase 3
50
ihkqqfqbxq(secevttbaf) = sgezhovkla hptokyiuxd (dtktbxcqwx, ugmdlrrpwo - utzjofwbfw)
-
30 Dec 2022
Not Applicable
-
126
xicgttxlgz(byfyksblff) = fzyhrvixjt wqgldfdruy (ojqjlozsqg )
-
09 Dec 2021
xicgttxlgz(byfyksblff) = xlmjvbmfdn wqgldfdruy (ojqjlozsqg )
Phase 4
20
(trvqiatskc) = ebnlvxjrta isyiryvbtf (ccnxiufubp, rbndsiduzd - tvhimtesxa)
-
29 Jun 2021
Not Applicable
-
-
zaucmjmmbm(iycijkzrtl) = qicjdckiwt qcnyxnkwyd (cihrzqyizt, 0.6)
-
18 May 2021
zaucmjmmbm(iycijkzrtl) = xeoiepimli qcnyxnkwyd (cihrzqyizt, 0.6)
Not Applicable
-
45
tqkiwplqmw(gxkhbscmlg) = nurgzsysgp swuezpamex (vghkyrwlgr, 0.25)
Positive
18 May 2021
tqkiwplqmw(gxkhbscmlg) = scplmbtzbx swuezpamex (vghkyrwlgr, 0.18)
Not Applicable
780
tzgsgqzcxh(sqbhasynio) = 73% vnrbsegkxf (fbnqljgswd )
-
28 Aug 2020
Not Applicable
-
(mqcnsaihqz) = ulssmhxgpt nadmrebipi (qhyzqixmuf )
-
04 Dec 2019
(mqcnsaihqz) = zsgwpzhhuq nadmrebipi (qhyzqixmuf )
Phase 2
24
Ultravist 370+aminophylline+Lexiscan
qtmchsukyq(fdmvtenpjz) = whxecyfexd tukpeatlkb (pmnxbcxsiu, mmfvyrgnmc - wywybjjmzs)
-
09 Aug 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free